PT Kalbe Farma Tbk. (PTKFF) Stock Price, News & Analysis

Company Overview

PT Kalbe Farma Tbk is an Indonesia-based healthcare company that develops, manufactures, markets and distributes pharmaceutical and consumer healthcare products. Founded in 1966, the company has grown into one of Indonesia’s major healthcare businesses, serving consumers, healthcare professionals, hospitals and other institutional customers.

Kalbe Farma operates across several business segments, including prescription medicines, consumer health products, nutritional products and distribution and logistics services. Its portfolio includes branded generic and specialty medicines, over-the-counter products, health supplements, functional beverages, infant and adult nutrition products, and other health-related offerings. Through its distribution activities, the company also helps deliver pharmaceutical and consumer healthcare products to pharmacies, hospitals, clinics, modern retail outlets and other customers.

Headquartered in Jakarta, Kalbe Farma primarily serves the Indonesian market and has expanded its commercial activities into selected international markets, particularly across Southeast Asia and other parts of Asia. The company’s operations include research and development, manufacturing, marketing and nationwide distribution, supporting its position as an integrated healthcare provider.

Key Stats

• Today's Range: $0.05 to $0.05
• 50-Day Range: $0.04 to $0.05
• 52-Week Range: $0.04 to $0.10
• Volume: N/A
• Average Volume: 28,790 shs
• Market Capitalization: N/A
• P/E Ratio: 0.00
• Dividend Yield: 27,576.34%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:PTKFF
• CIK: N/A
• Web: www.kalbe.co.id
• Phone: 622142873888
• Fax: N/A
• Employees: 13,062
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 0.00
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A